DK-520

N/A

Report date: 2023/04/20 09:43:50
NME

Base Information

Drug NameDK-520
Drug Alias NameDK-520
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionWnt signalling pathway inhibitorsSerine/threonine-protein kinase TBK1 inhibitorsP38 mitogen-activated protein kinase inhibitors
TargetsSerine/threonine-protein kinase TBK1P38 mitogen-activated protein kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesDuke University
China Registration ClassN/A

Develop Information

Active CompaniesDuke University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A